Roxane Laboratories, Inc., manufacturer of LAAM, provides onsite training to clinics
that have received Food and Drug Administration (FDA) approval to administer
LAAM. Training can be tailored to address the needs of physicians, nurses, counselors,
or administrators. Depending on the needs of the clinic, training may be
conducted in a couple of hours or a full day. A number of informational brochures,
as well as a videotape, are available for physicians, counselors, and patients.
There is no charge for the training. More information can be received
by writing to Roxane Laboratories, Inc., P.O. Box 16532, Columbus, Ohio 43216,
or by calling (614) 276-4000.
CSAT implemented the Opioid Addiction Treatment Improvement Project (OATIP)
as a nationwide initiative to enhance the quality and scope of drug treatment
for opioid-dependent populations in order to improve treatment effectiveness.
The primary purpose of technical assistance to single State agencies is
to improve clinical services management, quality assurance activities, evaluation,
and compliance with State and Federal regulatory requirements. The services
include national technical assistance (onsite and offsite); workshops with State
AOD directors, opioid addiction treatment providers, and other key agents in
related areas; and information dissemination on opioid treatment.
Site Map
Help
Account
Cart
Home
